Company Overview of Qiagen K.K.
Qiagen K.K. provides sample and assay technologies for research in molecular diagnostics, applied testing, pharma, and academic research. Its products include assay technologies for pathogen detection and genetic analysis, HLA, and haplotyping; molecular diagnostic tests; gene expression and silencing solutions. The company was founded in 1997 and is based in Tokyo, Japan. Qiagen K.K. operates as a subsidiary of Qiagen NV.
Forefront Tower II
13-1, Kachidoki 3-chome
Founded in 1997
81 3 6890 7290
81 3 5547 0818
Key Executives for Qiagen K.K.
Similar Private Companies By Industry
|Amano Enzyme Inc.||Asia|
|ArBlast Co., Ltd.||Asia|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Qiagen K.K., please visit www.qiagen.co.jp. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.